Sinil Pharmaceutical Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was KRW 25,444.29 million compared to KRW 20,396.46 million a year ago. Net income was KRW 3,468.39 million compared to KRW 2,457.41 million a year ago. Basic earnings per share from continuing operations was KRW 300 compared to KRW 213 a year ago. Basic earnings per share was KRW 300 compared to KRW 213 a year ago.
For the nine months, sales was KRW 65,332.06 million compared to KRW 59,128.63 million a year ago. Net income was KRW 8,963.04 million compared to KRW 8,495.73 million a year ago. Basic earnings per share from continuing operations was KRW 775 compared to KRW 735 a year ago. Basic earnings per share was KRW 775 compared to KRW 735 a year ago.